Deutsche Bank Ag\ Matinas Bio Pharma Holdings, Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $199,844 - $280,794	-252,968 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.6 - $1.41 $151,780 - $356,684	252,968 New	252,968 $275,000
Q4 2018 Feb 14, 2019	SELL	$0.53 - $1.11 $5,692 - $11,921	-10,740 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$0.35 - $0.92 $18,120 - $47,632	-51,774 Reduced 82.82%	10,740 $9,000
Q2 2018 Aug 14, 2018	SELL	$0.42 - $0.74 $11,344 - $19,988	-27,011 Reduced 30.17%	62,514 $26,000
Q1 2018 Oct 18, 2019	BUY	$0.76 - $1.32 $11,694 - $20,310	15,387 Added 20.75%	89,525 $68,000
Q1 2018 May 15, 2018	SELL	$0.76 - $1.32 $56,167 - $97,553	-73,904 Reduced 49.92%	74,138 $56,000
Q4 2017 Feb 14, 2018	BUY	$1.1 - $1.54 $105,659 - $147,923	96,054 Added 184.76%	148,042 $171,000
Q3 2017 Nov 14, 2017	BUY	$1.19 - $1.43 $61,865 - $74,342	51,988	51,988 $67,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $139M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.